课题基金 / 基金详情

Collaborative Research: Cyberplasm - An autonomous micro-robot constructed using synthetic biology

Collaborative Research: Cyberplasm - An autonomous micro-robot constructed using synthetic biology
合作研究:Cyber​​plasm - 使用合成生物学构建的自主微型机器人
批准号:
0943302
负责人:
Christopher Voigt
金额:
$41.97万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2012-03-31

项目摘要

项目成果

Christopher Voigt的其他基金

相似基金

相关文献

中文摘要
翻译
科学影响这项研究的目的是构建Cyberplasma,一个使用合成生物学原理的微型机器人。这将使用细胞设备集成,先进的微电子和仿生学的组合来实现;一种模仿动物模型的方法;在后者中,我们将模仿海洋动物海七鳃鳗的一些行为。合成肌肉将产生波动运动,推动机器人通过水。来自酵母细胞的合成传感器将报告来自直接环境的信号。这些信号将由电子神经系统处理。反过来,电子大脑将产生信号来驱动将使用葡萄糖作为能量的肌肉细胞。所有的电子元件都将由集成在机器人体内的微生物燃料电池供电。这项研究的目的是利用合成生物学的力量在细胞水平上整合特定的基因?零件?植入细菌、酵母和哺乳动物细胞中以实现类似装置的功能。此外,这种方法将允许细胞/细菌被“简化”,使得可以解决设备集成的输入/输出(I/O)要求。特别是,我们计划使用视觉感受器通过光信号将电子设备与感觉和驱动耦合。此外,合成生物学将在系统层面上进行,将多个细胞/细菌设备连接在一起,连接到电子大脑,实际上创造了一个多细胞生物混合微型机器人,我们命名为Cyberplasma。运动功能将通过工程化肌肉细胞来实现,使其具有兴奋/收缩偶联和收缩功能所需的最小细胞机制。肌肉将通过线粒体将葡萄糖转化为ATP来提供动力,ATP是生物细胞中的能量货币,因此将发电与驱动相结合。更广泛的领域Cyberplasma的发展将影响公众,私营部门和教育的想象力。机器人产业(在生物技术、医疗保健、农业和医疗保健方面)每年价值数十亿美元。混合生物/合成机器人将彻底改变这个行业的各个方面,使机器人能够以全新的控制和功能水平运行。这项研究解决的基本问题之一是将细菌整合到燃料电池中,以及将酵母和哺乳动物细胞分别整合到传感器和执行器等工程设备中。此外,我们将通过开发这些工程细胞与电子设备通信的机制来解决I/O问题。所获得知识(即在生物-电子界面)不仅将通过为新概念和发展奠定坚实的基础来推动该领域的发展,而且可能对医疗保健,其中生物传感器和药物输送系统可以通过利用这种细胞机器的感测能力和效率来大大改进。由于其?控制论由于这项计划的性质,它可有效地用作一种工具,以培养公众的热情和兴趣,特别是用于向小学至中学/高中的学生教授一般科学和合成生物学。
英文摘要
Scientific ImpactThe aim of this research is to construct Cyberplasm, a micro-scale robot using principles of synthetic biology. This will be accomplished using a combination of cellular device integration, advanced microelectronics and biomimicry; an approach that mimics animal models; in the latter we will imitate some of the behavior of the marine animal the sea lamprey. Synthetic muscle will generate undulatory movements to propel the robot through the water. Synthetic sensors derived from yeast cells will be reporting signals from the immediate environment. These signals will be processed by an electronic nervous system. The electronic brain will, in turn, generate signals to drive the muscle cells that will use glucose for energy. All electronic components will be powered by a microbial fuel cell integrated into the robot body. This research aims to harness the power of synthetic biology at the cellular level by integrating specific gene ?parts? into bacteria, yeast and mammalian cells to carry out device like functions. Moreover this approach will allow the cells/bacteria to be "simplified" so that the input/output (I/O) requirements of device integration can be addressed. In particular we plan to use visual receptors to couple electronics to both sensation and actuation through light signals. In addition synthetic biology will be carried out at the systems level by interfacing multiple cellular /bacterial devices together, connecting to an electronic brain and in effect creating a multi-cellular biohybrid micro-robot, we named Cyberplasm. Motile function will be achieved by engineering muscle cells to have the minimal cellular machinery required for excitation/contraction coupling and contractile function. The muscle will be powered by mitochondrial conversion of glucose to ATP, an energetic currency in biological cells, hence combining power generation with actuation.Broader AspectsThe development of Cyberplasm will impact the imagination of the general public, the private sector, and education in general. The robotics industry (in terms of biotech, healthcare, agriculture and healthcare) is worth billions of dollars annually. A hybrid bio/synthetic robot would completely revolutionize aspects of this industry allowing robots to operate with a whole new level of control and functionality. Amongst the fundamental issues that this research addresses is the integration of bacteria into fuel cells, as well as yeast and mammalian cells into engineered devices such as sensors and actuators, respectively. Moreover, we will address the I/O problem by developing mechanisms for these engineered cells to communicate with electronics. The knowledge to be gained (namely at the biology-electronics interface) will not only contribute to advance the field as such by laying a solid ground upon which novel concepts and developments can be built, but could have a far-reaching, longer term industrial impact in industries such as those healthcare, where biosensors and drug delivery systems could be vastly improved by harnessing the sensing capabilities and efficiency of such cellular machines. Owing to its ?cybernetic? nature, the project can be effectively used as a vehicle to foster the enthusiasm and interest of lay public and, specifically, for the teaching of science in general and synthetic biology to students, ranging from primary to secondary/high schools.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SemiSynBio: Collaborative Research: Very Large-Scale Genetic Circuit Design Automation
  • 批准号:
    1807575
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $100.0万
  • 财政年份:
    2018
  • 负责人:
    Christopher Voigt
  • 依托单位:
Synthetic Biology: Engineering, Evolution and Design (SEED) Conference 2014; Los Angeles, Manhatten Beach Marriott Conference Center, CA, July 14-17, 2014
Collaborative Research: Nitroplast: A Light-Driven, Synthetic Nitrogen-Fixing Organelle
  • 批准号:
    1331195
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $52.1万
  • 财政年份:
    2013
  • 负责人:
    Christopher Voigt
  • 依托单位:
Conference: Gordon Conference on Synthetic Biology: (Re-constructing and Re-programming Life at Mount Snow Resort, Vermont
  • 批准号:
    1341255
  • 项目类别:
    Standard Grant
  • 资助金额:
    $1.57万
  • 财政年份:
    2013
  • 负责人:
    Christopher Voigt
  • 依托单位:
国内基金
海外基金
Research on Quantum Field Theory without a Lagrangian Description
  • 批准号:
    24ZR1403900
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    SATOSHI NAWATA
  • 依托单位:
Cell Research
Cell Research
Cell Research (细胞研究)